UBS Group’s Cambrex Corporation CBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-211,768
Closed -$12.6M 8716
2019
Q3
$12.6M Buy
211,768
+199,588
+1,639% +$10.7M ﹤0.01% 1584
2019
Q2
$571K Buy
12,180
+1,602
+15% +$67.2K ﹤0.01% 4195
2019
Q1
$411K Sell
10,578
-13,092
-55% -$536K ﹤0.01% 4175
2018
Q4
$893K Sell
23,670
-37,447
-61% -$1.9M ﹤0.01% 3770
2018
Q3
$4.18M Sell
61,117
-37,194
-38% -$2.3M ﹤0.01% 2508
2018
Q2
$5.14M Buy
98,311
+58,563
+147% +$2.92M ﹤0.01% 2319
2018
Q1
$2.08M Buy
39,748
+12,489
+46% +$668K ﹤0.01% 3106
2017
Q4
$1.31M Buy
27,259
+13,420
+97% +$665K ﹤0.01% 3549
2017
Q3
$761K Sell
13,839
-7,182
-34% -$395K ﹤0.01% 3915
2017
Q2
$1.26M Buy
21,021
+2,435
+13% +$137K ﹤0.01% 3416
2017
Q1
$1.02M Sell
18,586
-4,973
-21% -$266K ﹤0.01% 3511
2016
Q4
$1.27M Buy
23,559
+16,680
+242% +$801K ﹤0.01% 3353
2016
Q3
$306K Sell
6,879
-15,425
-69% -$750K ﹤0.01% 4254
2016
Q2
$1.15M Sell
22,304
-30,626
-58% -$1.46M ﹤0.01% 3258
2016
Q1
$2.33M Sell
52,930
-70,984
-57% -$2.8M ﹤0.01% 2544
2015
Q4
$5.83M Buy
123,914
+33,205
+37% +$1.6M ﹤0.01% 1827
2015
Q3
$3.6M Buy
90,709
+43,633
+93% +$2.04M ﹤0.01% 2207
2015
Q2
$2.07M Buy
47,076
+15,917
+51% +$659K ﹤0.01% 2946
2015
Q1
$1.24M Buy
+31,159
New +$921K ﹤0.01% 3378

Other funds holding CBM

UBS Group's CBM Position: Q4 2019 in Review

UBS Group sold out of Cambrex Corporation (CBM) in Q4 2019, closing a stake of 211,768 shares — an estimated $12.6M sold.

UBS Group first reported a position in CBM in Q1 2015 and held it in 19 quarters. The position peaked at $12.6M in Q3 2019. 1 fund tracked by Wall St. Rank holds CBM as of Q4 2019.

  • UBS Group reported no remaining Cambrex Corporation position as of Q4 2019 after selling out during the quarter.
  • UBS Group sold 211,768 Cambrex Corporation shares in Q4 2019, an estimated $12.6M.
  • UBS Group first reported a position in Cambrex Corporation in Q1 2015 and held it in 19 quarters.
  • UBS Group's Cambrex Corporation position peaked at $12.6M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Cambrex Corporation as of Q4 2019.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.